BioSpace News Archive

The European Commission selected rqmicro, a Swiss startup company, among more than 1,200 competitors. This financial support accelerates the development and market launch of a revolutionary solution for the rapid detection of pathogenic microorganisms.

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, announced that Steve Eyl, Heska’s EVP of Global Sales & Marketing, and Jon Aagaard, Director of Investor Relations, will be holding one-on-one meetings at CL King’s 16th Annual Best Ideas Conference 2018 on Thursday, September 13, 2018.

DURECT Corporation (Nasdaq: DRRX) today announced that it has received a $5 million milestone payment from Indivior PLC (LON: INDV), triggered by Indivior’s approval of the New Drug Application (NDA) for PERSERIS™ (risperidone) in July 2018.

Sangamo Therapeutics, Inc. announced today that management will host a conference call on September 5th at 9:00 a.m. ET to discuss clinical data from the CHAMPIONS Study.

BioSpecifics Technologies Corp. today announced that BioSpecifics’ President, Tom Wegman, will present a corporate overview at the following upcoming conferences in September.

Magnolia Medical Technologies today announced the successful national launch and adoption of Steripath® Gen2.

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC.

AlEn USA, the makers of household cleaning products available worldwide, today announced its charitable partnership with the Curing Children’s Cancer Fund (CCCF) during the month of September, which is Children’s Cancer Awareness Month.

BlueWind Medical, developer of the RENOVA iStim(TM), an innovative, leadless, miniature, wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today the publication of long-term clinical results of OPTIMIST follow-up study.

Celsius Holdings, Inc. (Nasdaq: CELH), maker of the clinically proven, globally marketed performance CELSIUS® drinks, today announced that Target, GNC and 7-Eleven stores, along with Military Exchanges worldwide and top-tier fitness distributors and retailers nationwide, including Gold’s Gym corporate locations, will now sell CELSIUS®